Mysteries Solved: Comprehensive Evaluation of Circulating Abnormal Leukocytes
Speaker
Dr. Emily F. Mason, M.D., Ph.D.
Assistant Professor of Pathology, Microbiology, and Immunology,
Division of Haematopathology Vanderbilt University Medical Center,
Nashville, TN, USA
Dr Emily F. Mason currently serves as an Assistant Professor of Pathology, Microbiology and Immunology, Division of Haematopathology, Vanderbilt Medical Centre in Nashville Tennessee. She received her B.S. from Harvard University and graduated with an MD degree from Duke University, Durham, and subsequently pursued her PhD on the topic of “Glucose Metabolism and p53 in Leukaemia”. In addition to her active teaching roles, Dr Mason is an avid researcher, having published close to 20 peer-reviewed articles and book chapters on haematopathology. She has also been invited to speak and present her work in both international and local conferences, including the prestigious United States and Canadian Academy of Pathology Annual Meeting.
Moderator
Dr Siew Lian, Chong, MD (MMA)
Haematology Resident, Haematology Dept,
Ampang Hospital, Selangor, Malaysia
Dr Chong is currently a Haematology Resident at Hospital Ampang, Selangor, Malaysia. She received her MD degree from the Moscow Medical Academy. Her achievement includes being the recipient of the International Society of Laboratory Haematology (ISLH) Trainee Award in 2021. Her main research interest is in the molecular genetics of leukaemias.
Objectives
• Review the peripheral blood smear morphology of various abnormal leukocytes
• Interpret flow cytometry data from specimens with an abnormal WBC differential
• Review how morphologic, flow cytometric and genetic data are integrated to evaluate circulating abnormal leukocytes
Abstract of Lecture:
Flow cytometry and genetic testing have become integral tools in the work-up of haematologic disorders. In this webinar, Dr. Emily Mason and Dr. Chong Siew Lian will present a series of case studies that demonstrate the clinical utility of these technologies in the assessment of circulating abnormal leukocytes. The discussion will highlight the benefits of flow cytometry to quickly and accurately identify abnormal cell populations and guide further ancillary testing.
We hoped you have enjoyed the webinar and gained new insights!
May we request your time for a short survey?